[HTML][HTML] Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

L Shu, C Niu, R Li, T Huang, Y Wang, M Huang… - Stem cell research & …, 2020 - Springer
Background COVID-19 is a highly infectious respiratory disease. No therapeutics have yet
been proven effective for treating severe COVID-19. Objectives To determine whether …

[PDF][PDF] Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

L Shu, C Niu, R Li, T Huang, Y Wang, M Huang, N Ji… - 2020 - medmatrixusa.com
Background: COVID-19 is a highly infectious respiratory disease. No therapeutics have yet
been proven effective for treating severe COVID-19. Objectives: To determine whether …

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.

L Shu, C Niu, R Li, T Huang, Y Wang… - Stem Cell Research & …, 2020 - go.gale.com
Background COVID-19 is a highly infectious respiratory disease. No therapeutics have yet
been proven effective for treating severe COVID-19. Objectives To determine whether …

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

L Shu, C Niu, R Li, T Huang, Y Wang, M Huang, N Ji… - 2020 - agris.fao.org
Background COVID-19 is a highly infectious respiratory disease. No therapeutics have yet
been proven effective for treating severe COVID-19. Objectives To determine whether …

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.

L Shu, C Niu, R Li, T Huang, Y Wang… - Stem Cell Research …, 2020 - search.ebscohost.com
Background: COVID-19 is a highly infectious respiratory disease. No therapeutics have yet
been proven effective for treating severe COVID-19. Objectives: To determine whether …

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

L Shu, C Niu, R Li, T Huang, Y Wang… - Stem Cell Research …, 2020 - search.proquest.com
Background COVID-19 is a highly infectious respiratory disease. No therapeutics have yet
been proven effective for treating severe COVID-19. Objectives To determine whether …

[引用][C] Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

L Shu, C Niu, R Li, T Huang, Y Wang… - Stem Cell Research & …, 2020 - jglobal.jst.go.jp
N Engl J Med; Clinical characteristics of coronavirus disease 2019 in China; WJ Guan, ZY
Ni, Y Hu, WH Liang, CQ Ou, JX He; 382; 2020; 1708-1720; citation_id= CR1Zhou P, Yang …

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

L Shu, C Niu, R Li, T Huang, Y Wang… - Stem cell research …, 2020 - pubmed.ncbi.nlm.nih.gov
Background COVID-19 is a highly infectious respiratory disease. No therapeutics have yet
been proven effective for treating severe COVID-19. Objectives To determine whether …

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

L Shu, C Niu, R Li, T Huang, Y Wang… - Stem Cell Research & …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
COVID-19 is a highly infectious respiratory disease. No therapeutics have yet been proven …

[PDF][PDF] Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

L Shu, C Niu, R Li, T Huang, Y Wang, M Huang, N Ji… - 2020 - unoeste.br
Background: COVID-19 is a highly infectious respiratory disease. No therapeutics have yet
been proven effective for treating severe COVID-19. Objectives: To determine whether …